Novel molecular adducts of an anti-cancer drug vandetanib with enhanced solubility-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel molecular adducts of an anti-cancer drug vandetanib with enhanced solubility

Published:2024 Issue:3 Volume:26 Page:248-260
ISSN:1466-8033
Container-title:CrystEngComm
language:en
Short-container-title:CrystEngComm

Author:

Bandaru Ravi Kumar¹,Giri Lopamudra¹,Krishna Gamidi Rama²^ORCID,Dandela Rambabu¹^ORCID

Affiliation:

1. Department of Industrial and Engineering Chemistry, Institute of Chemical Technology-Indian Oil Bhubaneswar Campus, Bhubaneswar, India

2. Organic Chemistry Division, CSIR-National Chemical Laboratory, Dr. Homi Bhabha Road, Pune 411008, India

Abstract

Successful attempt to improve the solubility and dissolution rate of Vandetanib - an anti-cancer drug, by crystal engineering approach.

Funder

Science and Engineering Research Board

Publisher

Royal Society of Chemistry (RSC)

Subject

Condensed Matter Physics,General Materials Science,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2024/CE/D3CE01130E

Reference45 articles.

1. Evaluating parameters affecting drug fate at the intramuscular injection site

2. Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development

3. Whole body physiologically-based pharmacokinetic models: their use in clinical drug development

4. Nanostructured Lipid Carriers- A Versatile Carrier for Oral Delivery of Lipophilic Drugs

5. The use of solubility parameters in pharmaceutical dosage form design

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP